They demonstrated that the presence of COMP in the sera of patients with chronic liver diseases is strongly associated with liver cirrhosis and that increased COMP levels appear to identify a subgroup of patients who are at increased risk of their disease progressing to HCC and liver-related mortality. Here, COMP is linked to cirrhosis of liver.